Ardent Health Inc. cash flow to debt ratio of 20.78% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Ardent Health Inc.'s free cash flow has increased 102.80% from $127.52M last year to $258.61M, signaling increasing performance

Ardent Health Inc.'s debt to equity ratio is 1.32, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy

Ardent Health Inc.'s debt has decreased relative to shareholder equity from 2.02 last year to 1.32 today, signaling strengthened financials

Ardent Health Inc. has a net debt to EBITDA ratio of 3.13x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk

Ardent Health Inc.'s interest coverage ratio of 11.15 indicates that earnings with good margin can cover interest payments on company debt

Ardent Health Inc.'s profit margin has decreased (-40.76%) in the last year from 3.53% to 2.09%, signaling decreasing performance

Ardent Health Inc.'s short-term assets of $2.06G exceed its short-term liabilities of $1.05G

Ardent Health Inc.'s return on assets of 2.56% is lower than the 5.00% threshold, indicating inefficient asset utilization

Ardent Health Inc.'s return on equity of 9.08%, is lower than 15.00%, indicating bad performance

Ardent Health Inc.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

Ardent Health Inc. had positive net income in 5.00 out of 5 years, indicating stable and consistent earnings

Ardent Health Inc. has positive free cash flow, indicating the company generates cash after capital expenditures

Ardent Health Inc. has a free cash flow yield of 18.41%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Ardent Health Inc.'s yearly earnings has decreased -35.43% since last year from $210.34M to $135.81M, signaling decreasing performance

Ardent Health Inc.'s yearly revenue has increased 6.01% since last year from $5.97G to $6.32G, signaling increasing performance

ROIC 10.66% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.

Ardent Health Inc.'s 3-year revenue CAGR of 7.23% is positive, indicating growing revenue over the past 3 years

Ardent Health Inc. had revenue growth in 4.00 out of 5 years, indicating consistent revenue performance

Ardent Health Inc. had positive ROE in 4.00 out of 5 years, indicating consistent and reliable returns on equity

Ardent Health Inc. has insufficient data to evaluate this check.

Ardent Health Inc. has an earnings yield of 9.70%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings

Ardent Health Inc. is undervalued relative to its fair value price of 12.68 based on EBITDA multiple model

Ardent Health Inc. has an EV/EBITDA ratio of 5.95x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

Ardent Health Inc. is undervalued relative to its fair value price of 42.73 based on Earnings Fair Value model

Ardent Health Inc. has no meaningful EPS growth rate; PEG ratio cannot be computed.

Ardent Health Inc. has a price-to-book ratio of 0.80x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Ardent Health Inc. has a price-to-sales ratio of 0.22x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue